Cited by 69Multiple Sclerosis Research StudiesGenetic Associations and EpidemiologyGenomics and Chromatin Dynamics

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

Open access
Alcina, Antonio, Fedetz, Maria, Fernández, Óscar, Saiz, Albert, Izquierdo, Guillermo, Lucas, Miguel, Leyva, Laura, García-León, Juan-Antonio +17 more·2013·Journal of Medical Genetics

Abstract

Background and aim: Several studies have highlighted the association of the 12q13.3–12q14.1 region with coeliac disease, type 1 diabetes, rheumatoid arthritis and multiple sclerosis (MS); however, the causal variants underlying diseases are still unclear. The authors sought to identify the functional variant of this region associated with MS. Methods: Tag-single nucleotide polymorphism (SNP) analysis of the associated region encoding 15 genes was performed in 2876 MS patients and 2910 healthy Caucasian controls together with expression regulation analyses. Results: rs6581155, which tagged 18 variants within a region where 9 genes map, was sufficient to model the association. This SNP was in total linkage disequilibrium (LD) with other polymorphisms that associated with the expression levels of FAM119B, AVIL, TSFM, TSPAN31 and CYP27B1 genes in different expression quantitative trait loci studies. Functional annotations from Encyclopedia of DNA Elements (ENCODE) showed that six out of these rs6581155-tagged-SNPs were located in regions with regulatory potential and only one of them, rs10877013, exhibited allele-dependent (ratio A/G=9.5-fold) and orientation-dependent (forward/reverse=2.7-fold) enhancer activity as determined by luciferase reporter assays. This enhancer is located in a region where a long-range chromatin interaction among the promoters and promoter-enhancer of several genes has been described, possibly affecting their expression simultaneously. Conclusions: This study determines a functional variant which alters the enhancer activity of a regulatory element in the locus affecting the expression of several genes and explains the association of the 12q13.3–12q14.1 region with MS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmedgenet-2012-101085

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. [1]Hauser SL Oksenberg JR The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2009; 52: 61– 76 17015227
  2. [2]McElroy JP Oksenberg JR Multiple sclerosis genetics. Curr Top Microbiol Immunol 2008; 318: 45– 72 18219814
  3. [3]Ramagopalan SV Knight JC Ebers GC Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol 2009; 22: 219– 25 19387341
  4. [4]Manolio TA Collins FS Cox NJ Goldstein DB Hindorff LA Hunter DJ McCarthy MI Ramos EM Cardon LR Chakravarti A Cho JH Guttmacher AE Kong A Kruglyak L Mardis E Rotimi CN Slatkin M Valle D Whittemore AS Boehnke M Clark AG Eichler EE Gibson G Haines JL Mackay TF McCarroll SA Visscher PM Finding the missing heritability of complex diseases. Nature 2009; 461: 747– 53 19812666 PMC2831613
  5. [5]Bomprezzi R Kovanen PE Martin R New approaches to investigating heterogeneity in complex traits. J Med Genet 2003; 40: 553– 9 12920061 PMC1735544
  6. [6]Fierabracci A Milillo A Locatelli F Fruci D The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. Autoimmun Rev. Published Online First: May 2012 doi: 10.1016/j.autrev.2012.04.007 22575366 · DOI
  7. [7]Corrado L Bergamaschi L Barizzone N Fasano ME Guerini FR Salvetti M Galimberti D Benedetti MD Leone M D'Alfonso S Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. J Med Genet 2011; 48: 210– 11 21037273
  8. [9]Matesanz F González-Pérez A Lucas M Sanna S Gayán J Urcelay E Zara I Pitzalis M Cavanillas ML Arroyo R Zoledziewska M Marrosu M Fernández O Leyva L Alcina A Fedetz M Moreno-Rey C Velasco J Real LM Ruiz-Peña JL Cucca F Ruiz A Izquierdo G Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS One 2012; 7: e36140 22570697 PMC3343041
  9. [10]Kristjansdottir G Sandling JK Bonetti A Roos IM Milani L Wang C Gustafsdottir SM Sigurdsson S Lundmark A Tienari PJ Koivisto K Elovaara I Pirttilä T Reunanen M Peltonen L Saarela J Hillert J Olsson T Landegren U Alcina A Fernández O Leyva L Guerrero M Lucas M Izquierdo G Matesanz F Syvänen AC Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008; 45: 362– 9 18285424 PMC2564860
  10. [11]Goris A Boonen S D'hooghe MB Dubois B Replication of KIF21B as a susceptibility locus for multiple sclerosis. J Med Genet 2010; 47: 775– 6 20587413
  11. [12]Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824– 8 19525955
  12. [13]Raychaudhuri S Remmers EF Lee AT Hackett R Guiducci C Burtt NP Gianniny L Korman BD Padyukov L Kurreeman FA Chang M Catanese JJ Ding B Wong S van der Helm-van Mil AH Neale BM Coblyn J Cui J Tak PP Wolbink GJ Crusius JB van der Horst-Bruinsma IE Criswell LA Amos CI Seldin MF Kastner DL Ardlie KG Alfredsson L Costenbader KH Altshuler D Huizinga TW Shadick NA Weinblatt ME de Vries N Worthington J Seielstad M Toes RE Karlson EW Begovich AB Klareskog L Gregersen PK Daly MJ Plenge RM Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216– 23 18794853 PMC2757650
  13. [14]Zhernakova A Stahl EA Trynka G Raychaudhuri S Festen EA Franke L Westra HJ Fehrmann RS Kurreeman FA Thomson B Gupta N Romanos J McManus R Ryan AW Turner G Brouwer E Posthumus MD Remmers EF Tucci F Toes R Grandone E Mazzilli MC Rybak A Cukrowska B Coenen MJ Radstake TR van Riel PL Li Y de Bakker PI Gregersen PK Worthington J Siminovitch KA Klareskog L Huizinga TW Wijmenga C Plenge RM Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011; 7: e1002 PMC3044685 21383967
  14. [15]Alcina A Vandenbroeck K Otaegui D Saiz A Gonzalez JR Fernandez O Cavanillas ML Cénit MC Arroyo R Alloza I García-Barcina M Antigüedad A Leyva L Izquierdo G Lucas M Fedetz M Pinto-Medel MJ Olascoaga J Blanco Y Comabella M Montalban X Urcelay E Matesanz F The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 2010; 11: 439– 45 20508602
  15. [16]Fung EY Smyth DJ Howson JM Cooper JD Walker NM Stevens H Wicker LS Todd JA Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009; 10: 188– 91 19110536
  16. [17]Ramagopalan SV Dyment DA Cader MZ Morrison KM Disanto G Morahan JM Berlanga-Taylor AJ Handel A De Luca GC Sadovnick AD Lepage P Montpetit A Ebers GC Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 2011; 70: 881– 6 22190362
  17. [18]Bailey R Cooper JD Zeitels L Smyth DJ Yang JH Walker NM Hyppönen E Dunger DB Ramos-Lopez E Badenhoop K Nejentsev S Todd JA Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007; 56: 2616– 21 17606874 PMC2493063
  18. [19]Sundqvist E Bäärnhielm M Alfredsson L Hillert J Olsson T Kockum I Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet 2010; 18: 1349– 52 20648053 PMC3002863
  19. [20]Gandhi KS McKay FC Cox M Riveros C Armstrong N Heard RN Vucic S Williams DW Stankovich J Brown M Danoy P Stewart GJ Broadley S Moscato P Lechner-Scott J Scott RJ Booth DR; ANZgene Multiple Sclerosis Genetics Consortium The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet 2010; 19: 2134– 43 20190274
  20. [21]Poser CM Paty DW Scheinberg L McDonald WI Davis FA Ebers GC Johnson KP Sibley WA Silberberg DH Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227– 31 6847134
  21. [22]Cavanillas ML Fernández O Comabella M Alcina A Fedetz M Izquierdo G Lucas M Cénit MC Arroyo R Vandenbroeck K Alloza I García-Barcina M Antigüedad A Leyva L Gómez CL Olascoaga J Otaegui D Blanco Y Saiz A Montalbán X Matesanz F Urcelay E Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes Immun 2010; 12: 110– 15 20944657
  22. [23]Wigginton JE Cutler DJ Abecasis GR A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 887– 93 15789306 PMC1199378
  23. [24]Benjamini Y Hochberg Y Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Sic B 1995; 57: 289– 300
  24. [25]Sarkar SK False discovery and false nondiscovery rates in single-step multiple testing procedures. Ann Stat 2006; 34: 394– 415
  25. [26]Barrett JC Fry B Maller J Daly MJ Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21: 263– 5 15297300
  26. [27]Zeller T Wild P Szymczak S Rotival M Schillert A Castagne R Maouche S Germain M Lackner K Rossmann H Eleftheriadis M Sinning CR Schnabel RB Lubos E Mennerich D Rust W Perret C Proust C Nicaud V Loscalzo J Hübner N Tregouet D Münzel T Ziegler A Tiret L Blankenberg S Cambien F Genetics and beyond—the transcriptome of human monocytes and disease susceptibility. PLoS One 2010; 5: e10693 20502693 PMC2872668
  27. [28]Dixon AL Liang L Moffatt MF Chen W Heath S Wong KC Taylor J Burnett E Gut I Farrall M Lathrop GM Abecasis GR Cookson WO A genome-wide association study of global gene expression. Nat Genet 2007; 39: 1202– 7 17873877
  28. [29]Montgomery SB Sammeth M Gutierrez-Arcelus M Lach RP Ingle C Nisbett J Guigo R Dermitzakis ET Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010; 464: 773– 7 20220756 PMC3836232
  29. [30]Stranger BE Nica AC Forrest MS Dimas A Bird CP Beazley C Ingle CE Dunning M Flicek P Koller D Montgomery S Tavaré S Deloukas P Dermitzakis ET Population genomics of human gene expression. Nat Genet 2007; 39: 1217– 24 17873874 PMC2683249
  30. [31]Dimas AS Deutsch S Stranger BE Montgomery SB Borel C Attar-Cohen H Ingle C Beazley C Gutierrez Arcelus M Sekowska M Gagnebin M Nisbett J Deloukas P Dermitzakis ET Antonarakis SE Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009; 325: 1246– 50 19644074 PMC2867218
  31. [32]Ceribelli M Dolfini D Merico D Gatta R Viganò AM Pavesi G Mantovani R The histone-like NF-Y is a bifunctional transcription factor. Mol Cell Biol 2008; 28: 2047– 58 18212061 PMC2268390
  32. [33]Sakabe NJ Aneas I Shen T Shokri L Park SY Bulyk ML Evans SM Nobrega MA Dual transcriptional activator and repressor roles of TBX20 regulate adult cardiac structure and function. Hum Mol Genet 2012; 21: 2194– 204 22328084 PMC3335310
  33. [35]Pinskaya M Morillon A Histone H3 lysine 4 di-methylation: a novel mark for transcriptional fidelity? Epigenetics 2009; 4: 302– 6 19633430
  34. [36]Li G Ruan X Auerbach RK Sandhu KS Zheng M Wang P Poh HM Goh Y Lim J Zhang J Sim HS Peh SQ Mulawadi FH Ong CT Orlov YL Hong S Zhang Z Landt S Raha D Euskirchen G Wei CL Ge W Wang H Davis C Fisher-Aylor KI Mortazavi A Gerstein M Gingeras T Wold B Sun Y Fullwood MJ Cheung E Liu E Sung WK Snyder M Ruan Y Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012; 148: 84– 98 22265404 PMC3339270
  35. [38]Adams JS Hewison M Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys 2012; 523: 95– 102 22446158 PMC3361592
  36. [39]Simon KC Munger KL Kraft P Hunter DJ De Jager PL Ascherio A Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Neurol 2011; 258: 1676– 82 21431378 PMC3746024
  37. [40]Orton SM Morris AP Herrera BM Ramagopalan SV Lincoln MR Chao MJ Vieth R Sadovnick AD Ebers GC Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008; 88: 441– 7 18689381 PMC2740974
  38. [41]Lange CM Bojunga J Ramos-Lopez E von Wagner M Hassler A Vermehren J Herrmann E Badenhoop K Zeuzem S Sarrazin C Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 2011; 54: 887– 93 21145801
  39. [42]Szodoray P Nakken B Gaal J Jonsson R Szegedi A Zold E Szegedi G Brun JG Gesztelyi R Zeher M Bodolay E The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008; 68: 261– 9 18510590

Cited by

Sorted by citations

Authors
Alcina, A., Fedetz, M., Fernández, Ó., Saiz, A., Izquierdo, G., Lucas, M., Leyva, L., García-León, J.-A., Abad-Grau, M. D. M., Alloza, I., Antigüedad, A., Garcia-Barcina, M. J., Vandenbroeck, K., Varadé, J., de la Hera, B., Arroyo, R., Comabella, M., Montalban, X., Petit-Marty, N., Navarro, A., Otaegui, D., Olascoaga, J., Blanco, Y., Urcelay, E., & Matesanz, F.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Department of Cell Biology and Immunology Instituto de Parasitología y Biomedicina ‘López Neyra’, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain
  • Hospital Regional Universitario de Málaga (ES)
  • Hospital Clínic de Barcelona (ES)
  • Hospital Universitario Virgen Macarena (ES)
  • Laboratorio de Investigación, Instituto de Neurociencias Clínicas, Hospital Regional Universitario Carlos Haya, Málaga, Spain
  • Departamento de Lenguajes y Sistemas Informáticos, CITIC, Universidad de Granada, Granada, Spain
  • University of the Basque Country (ES)
  • Hospital de Basurto (ES)
  • Servicio de Genética, Hospital de Basurto, Bilbao, Spain
  • Ikerbasque (ES)
  • Hospital Clínico San Carlos (ES)
  • Immunology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain
  • Vall d'Hebron Hospital Universitari (ES)
  • Centre d'Esclerosi Múltiple de Catalunya, CEM-Cat, Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d´Hebron (HUVH), Barcelona, Spain
  • Institute of Evolutionary Biology (UPF-CSIC), PRBB, Barcelona, Spain
  • Institució Catalana de Recerca i Estudis Avançats (ES)
  • Biogipuzkoa Health Research Institute (ES)
  • Donostiako Unibertsitate Ospitalea (ES)
Corresponding author
  • Alcina, Antonio
  • Matesanz, Fuencisla
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2012-11-17
Volume
50
Issue
1
Pages
25-33
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2155661622
Cited by
69
References
3
Citations by year
2026: 4 · 2025: 5 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 7 · 2014: 2 · 2013: 5
FWCI
3.20
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Journal of Medical Genetics (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion, other-oa)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by-nc)
  • Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by-nc-nd)
Funders
  • Ministerio de Economía y Competitividad
  • Ikerbasque, Basque Foundation for Science
  • Junta de Andalucía
  • European Regional Development Fund
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
multiple sclerosis, functional variants, enhancer activity, gene expression regulation, expression quantitative trait loci, enhancer-promoter interactions, KIF5A, CYP27B1, linkage disequilibrium
MeSH terms
Chromosome Mapping, Chromosomes, Human, Pair 12, Enhancer Elements, Genetic, Humans, Methyltransferases, Multiple Sclerosis, Transcription, Genetic, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase, Kinesins, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review